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Magneticallyrecoverable,semipermieablemirocapsuleshavebeendevisedforcovalententrapmentofreactivesubstances
intheintestinalcavitytobiomonitorpotentiallyDNA-damagingagentsandtheeffectsofetiologicallyimportantcomponents
ofthehumandiet. Thesemiarocapsuleshavebeenshowntotrapfivetypesofagentsin wvo,nanely,carcinogenelectrophiles,
nitrosating agents, mutagens/carcinogens havingaplanarmolecularstructure, andas-yetunidentifiedendogenouscross-
linking agents and precursors ofreactive osygen species. Substantial alterations in bothtotal metabolites and types of
metabolites trapped from[14Cjbenzo(a)pyrene werefound tobecausedby increasing (withinthehumanintake range)
thedietary levelsofbeefproteinanddietaryfiber. Thesystemthusrespondstoavariety ofpotentially criticalagentsand
ina mannerconsistent withepidemiologicallyimportantdietary modulatorsforcolorectalcarcinogenesis. Wrktoward
recognizing entrapped endogenous agents hasalso begun.
Introduction
Because the humandiet (1) andgastrointestinal (GI) sites (2)
have the major nontobacco roles in human carcinogenesis, the
general aimofour workhas been thedevelopment and use ofa
system capable of selectively trapping otherwise inaccessible
DNA-damaging agents in the human GI tract. To facilitate the
short-term molecular identification ofGIcarcinogens andtheir
dietary sources, ourworkhas involveddevising notonly a means
ofmonitoringthelowerGItractbutalsomethodstoindependent-
ly test the influences of single components ofhuman diets on
(model) carcinogens within the GI cavity. The work reviewed
hereisthedevelopmentofrecoverablemicroencapsulated targets
(3), their applications inthe useofcarcinogens and precursors,
the first useofhuman diets altered systematically in colorectal
(CR) cancer risk components (4,5), and an introduction to the
first useofthese microcapsules inhumans, whichis reported in
detail elsewhere in this issue (6).
Since theinconclusive 1987 reviewbyBruce(7) onpostulated
determinants ofCR cancer, a series ofimportant findings have
beenmade: a) ras oncogeneactivationandp53inactivation were
found, respectively, inhalfor mostofCR cases (8); b) different
acetylator status was found for CR cases (9); c) the principal
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fecalmutagen(fecapentaene) wasdemonstratedasarodentcar-
cinogen (10,11) andCRcases werefoundtohavea6-fold lower
stool residual concentrationoffecapentaenethancontrols (12);
d)dietary ironandphytate, respectively, were showntoenhance
or decrease 1,2-dimethylhydrazine (DMH)-induced tu-
morigenesis(13,14), andhumanfeceswereshowntocontainvery
highlevelsofhydroxylradicalgenerators (15), allinaccordwith
the hydroxyl radical hypothesis ofGrafand Eaton (16); e) the
proteinkinaseC activatordiacylglycerol wasfoundtobeproduc-
edbyintestinalmicroflora(17); andJ) several studiesinhumans
confirmedtheCR-protectiveeffectsofbulkingfiber, antioxidant
vitamins, andcalcium (18-20). Thelastfourfindings involving
substances or sources passing through the GI cavity (together
withclassical studiesondietary/microfloral manipulationofex-
perimental CRcarcinogenesis) indicatethattheGIcavity isthe
principal source ofCRcarcinogenic agents.
Although entrapment within the GI cavity could reveal sub-
stancesofinterest, thethreefollowingconundrumsnevertheless
had tobe faced: a) Ifwe do not know what types ofsubstances
aretobetrapped, whattypeoftrapping systemshouldbeused?
b) Sincemanydietary interactions arealreadyknown, yetcom-
pletehumandietstypicalofhumaneverydayconsumptionhave
neverbeenused inexperimental animals, how canwequantify
and control the probable (major?) influences on microcapsule
trapping ofmodel carcinogens by dietary risk factors already
shown by epidemiological means? c) Since GI transit time is
typically severaldaysanddietary intervention studiesrequireat
least several weeks, how can short-term monitoring be usedO'NEILL ETAL.
toapproachlong-term, multistage carcinogenesis? We are con-
sidering here our mostextensiveenvironmental exposurethat oc-
curs whether or not the individual has other lifestyle or work-
place exposures, andforwhichhighlydevelopedtechniqueshave
long been used in clinical nutrition studies. The GI milieu re-
quiresonly afewtransittimes toadaptto achosendietandto pro-
duce new agents ofinterest, andthis must notbeconfusedwith
themonthsofdietary interventionneeded toobservechangesin,
say, cellularproliferation rates. Hencethebriefnessbothofadap-
tation and ofmicrocapsule exposure provides realistic oppor-
tunities tocorrelate thechanges inwhatmicrocapsules trapwith
aseriesofsystematicchangesindiet; CRriskfactorsestablished
already through long-termepidemiological studiesandmedium-
term intervention studies can be used as benchmarks.
Basic Featuresforthe Monitoring
System
Excretable Microcapsules within the GI tract
The basic idea is to orally administer millions of small mi-
crocapsules thatdisperse withintheGItractandcollectively pro-
vide alargesurface areafortrappingreactivesubstancesthatpro-
bably would notbeexcreted intothefeces. Subsequentfecal ex-
cretion ofthe microcapsules with reactive agents trapped and
protected within the microcapsule interior shouldprecludeloss
ofreactive agents (Table 1)by mucosal absorption ormicrofloral
metabolism.
PreparationandBasicPropertiesofMicrocapsules
As Traps for Alkylating Agents
Although microencapsulation has permitted the controlled
release ofpharmaceuticals, pesticides, andotheragentsthrough
the destruction ofthe membrane encapsulating theactiveprin-
cipal, we needed to produce microcapsules that are stable and
selectively entrap low molecular weight substances that enter
through asemipermeablemembrane(3). Several majoradvan-
tages arerealizedwith amembrane thatbothexcludes enzymes,
bacteria, andmacrophages, which coulddestroy theentrapped
carcinogen, and also retains a water-soluble macromolecular
target insidethemicrocapsules. Because mostcovalent-binding
reactionsofDNA (notnecessarilythose mostimportantin caus-
ingmiscoding) are onthenitrogenatomsofguanineandadenine,
weusedpolyethyleneimine (PEI) as afirstapproach to a DNA
surrogate. For simple use, we arranged a quick method of
recovery fromfecesbyincludingmagnetiteinthemicrocapsules.
There is substantial art inproducing microcapsules and minor
charges in production conditions commonly give inexplicable
andprofoundalterationstomicrocapsulebatches; nevertheless,
the conditions were optimized for membranes of poly
(hexamethylene-terephthalamide) grafted onto PEI so as to
enabletrapping of['4CH3]-N-nitrosomethylurea (NMU) in vivo
(21,22).
Several keyfeatures weredemonstratedduringtheearly work:
a) microcapsules werecapable ofentrapping substances up to a
molecularweightofabout 1000in vitro; b) useofhemoglobin in-
steadofPEIresulted in microcapsules that were proteolytical-
lyunstable, presumablydue tohemoglobinmoleculeswithinthe
membranebeingavailable toenzymicattack; c) rats showed no
evidence ofdistress or harm from gavage treatments with the
microcapsules; d) microcapsules could be recovered intact by
simple magnetic means from the feces; e) the microcapsules
couldbebrokenultrasonically aftertreatmentin vivowith 14C-
labeledNMU ormethyl iodide, toshow a core versusmembrane
distribution of PEI; J) which in turn was radically altered by
changes in membrane formulation; g) microcapsules after GI
transit unexpectedly became stronger (more resistant to
ultrasonic rupture).
Inanotherstudy (23), entrapmentinvwvo was shownfor anIP-
administered carcinogen requiring metabolic activation,
dimethylhydrazine (DMH). Thetime courseoftrapping show-
ed thatmicrocapsules administered more than 2 hr after injec-
tion of DMH trapped relatively much less of the DMH dose
presumablybecausetheywvrenotinpositionforbiliary-excreted
metabolites. For ['4C]NMU administered intrarectally, only
microcapsules givenby gavage withinthe time 4 to 8 hr before
showed anytrapping. Thatis, themicrocapsules had toreachthe
rectum to be in position to intercept the electrophilic species
TIble 1. Substances detected inGIcavity by IARCmncrocapsules.a
Reactant In vitro In vio Diet effect Microcapsuletype" Assaytypec Substances
Direct-acting carcinogen
electrophiles x x - 1,2,3 RA NMU, MMS, CH3I
Carcinogen with host IQ BaP, PhIP
activation - x x 1,2,3,4 RA DMH
Planar structure IQBaP, PhIP,
carcinogen x x - 1,4 RA, C Glu-P-1, endogenous
N-nitrosating agents x x - 1,5 TEA Nitrite/drinking water
Cross-linking agents x x x 4,5 M/T Many, endogenous
Reactive oxygen species
and precursors x x x 5 RA H202, endogenous
Abbreviations: NMU, N-nitrosomethylurea; MMS, methylmethane sulfonate; IQ, 2-amino-3-methylimidazo[4,5-Aquinoline; BaP, benzo[alpyrene; PhIP,
6-phenyl-2-amino-1-methylimidazo[4,5-Apyridine; DMH, difethylhydrazine; Glu-P-1,2-amino-6-methyldipyridol[1,2-inuidazole; endogenous, as-yetuniden-
tified endogenous agents.
a(x) Successful demonstration, (-) notdemonstrated.
b Microcapsule types were 1, PEI; 2, poly(vinyl alchololtriethyleneteramine) (PVA-TET); 3, PVA-TETacetylated; 4, PEI CPTS; and 5, 14CH3-labeled PEI.
CAssay types were RA, radioactive counting; C, HPLC; TEA, thermal energy analyzer; M/T, large alteration to ratiomembrane/ttal label distribution.
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from the fast-decomposing NMU. They were still able to per-
form such trapping after hours of admixture with intestinal
contents.
A more detailed investigation (24) in trapping ['4C]ben-
zo[a]pyrene(BaP) metabolites showedthatasingledoseofBaP
given by gavage yielded trappable metabolites mostly inthe first
48 hr. The pattern of14Cactivity in anextraction sequence (A,
methanol-NH40H desorption; B, acidhydrolysis; C, solventex-
traction; D, inextractable) was unlike either that from simple
mixing ofmicrocapsules with fecescontaining BaPmetabolites
or in vitro treatment with 7,8-dihydroxy,-9,10-epoxy-7,8,9,10-
tetrahydrobenzo(a)pyrene. OftheHPLC-identifiedmetabolites,
the 1,6- and 3,6-diones were predominant, and desorbable
metabolites were mostly unconjugated.
A further study (25) with the protein pyrolysates 2-amino-
3-methylimidaza[4,5-J]quinoline (IQ)and6-phenyl-2-amino-l-
methylimidazo[4,5-Apyridine (PhIP) has shown both substances
tobetrappedin vivo. Thus, forallalkylatingagentsadministered
by different routes, trapping within the GI cavity was dem-
onstrated provided thatthemicrocapsules werepresentatatime
when electrophilic products could beexpected tobe present in
the local GI segment. The products entrapped are thereby de-
rived from abriefexposureperiod, andthisfeaturehasthepoten-
tial for providing a better temporal discrimination of their
sources than, say, long-term integration by adducts on blood
proteins.
Endogenous Cross-Linking and Nitrosating
Agents
Further investigation ofthe surprising finding thatmicrocap-
sules became stronger in the GI tract concluded that this was
causedby cross-linking ofavailable PEIamines, leading toboth
intramembrane reactions and core-membrane cross-linking
(26). Such effects could be produced in vivo with recognized
cross-linking agents, and with fecapentaene-12 and 4-hydro-
xynonenal, which are ofinterest as potential endogenous car-
cinogens. This work showed that endogenous cross-linking
agents are present extensively within the rat GI tract and were
present in both gastric and large bowel sections of chow-
consuming F344 rats. These effects were readily detected by
measuring the core-to-membrane shift of 14CH3 label in PEI
microcapsules, yielding acid-resistant cross-links in the large
bowel. A recentstudy hasshownthepresenceofextensivecross-
linking agents presence inhumans (6), with even largereffects
obtainedby48hranaerobicincubationwithfecalslurries. Cross-
linking agents are inherently ofconsiderable interest, as they
would seemtobebifunctionalalkylating, membrane-penetrating
agents. Manycross-linking agents arecarcinogens(27,28), able
to activatefos oncogene (29), and are particularly potent mu-
tagens inDrosophila (30). Although wearenotyetabletoiden-
tify them (indeed there is no other detection system for cross-
linking agents), their presence deserves further investigation.
The detection of endogenous nitrosating agents through
urinaryN-nitrosoprolineexcretion (31 initiatedmany studies in
this field. Because the pKa of the PEI homologue piperazine
renders it much more susceptible to nitrosation than the PEI
homologueofproline (32), thenitrosationofPEImicrocapsules
was studied (33). Thecapsules werefoundtobenitrosatedwith
a pH profile similar to amides rather than amines, which was
ofinterestbecausethemajornitrosatable substratesatgastricpH
are believed to be amides (34). In vivo nitrosation was dem-
onstrated (33) andpreliminary resultssuggestthattheyaremuch
more effective in trapping nitrosating agents thanproline.
MutagensandCarcinogenswithPlanarMolecular
Structures
In examining the trapping of['4C]BaP in vivo, it was found
(24)thatabout25% oftotal radioactivity couldbedesorbedwith
the methanol-NH40H mixture used for extracting adsorbed
mutagens/carcinogens with a planar molecular structure from
bluecotton (35). Becausebluecottoncannotbereadily ingested,
we covalently modified PEI microcapsules with the copper
phthalocyanine tetrasulfonic acid moiety (CPTS) used in blue
cotton. Theresultingblue-greenmicrocapsules haveshownan
enhancedpropensity toreversiblyabsorbbothBaP(36) andthe
proteinpyrolysates IQ, PhIP, and2-amino-6-methyldipyridol-
[1,2-a:3:2.-dJimidazole (Glu-P-1) (25). These were shown to
havealowernettrappingofBaPanditsmetabolitesin vitroand
in vivo, but ahigher proportion ofthetotal could be desorbed.
Theseresultsareofinterestbecauseseveral largegroupsofcar-
cinogens, including somecausing intestinal tumors, haveplanar
structures.
Effects ofIngestion ofMicrocapsules inRodents
Several studieswereundertakentodemonstrate lackofharm;
it should be noted that the human GI tract is exposed to huge
numbersofparticlesofthesizerangeofourmicrocapsulesboth
fromdustonvegetablesandfollowingthemucociliaryclearance
from the lungs of inhaled particles. Following five doses of
microcapsules, F344ratsshowedthesamemortalitypattern dur-
ing 120weeksashistorical controls (4). Notranslocationoutof
theGItractanda98.7% recoveryofradioactivity werefoundfor
rodentstreatedwith radiolabeledmicrocapsules (37). Chronic
dosingcaused noretentioninGIstructuresas seenwhenexamin-
ed microscopically.
Presenting DNA-Type Targets to Iden-
tify and Discriminate Important DNA-
Damaging Agents and TheirSources
Inourapproachtothelong-standing generalproblemofhow
totrapanddeterminethestructureofas-yetunidentified DNA-
damaging agents (38), weconsideredthefollowingthreelimita-
tions: a) theonlyhighly sensitive chemicalassayprocedures that
can provide structural information is mass spectrometry; b)
numerousbiological/biochemical assay systemscanindicatethat
DNA damage has taken place, butcannot specify what caused
thedamage; c)itcanbeexpectedthatalargeproportionofDNA-
damagingagentsgivenotumorigenic ormutationaloutcome, so
that somediscriminationis needed. Therefore, asoureventual
purpose is toidentifydietary riskfactors thatmustbeavoided,
thechoiceofbothtargetandassaytechniquesforsubstancestrap-
pedbymicrocapsules shouldprovidebothbiological relevance
and best chemical specificity for attribution to individual
sources. Thus, twotypesoftrappingagentortargetareneeded;
oneoflowmolecularweightthatcanenableidentification forat
least several types ofadducting substance by MS and/or 32p_
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Table2. Effectsofindependently altered human dietary macrocomponents offat, beefprotein, andfiber nonstarch polysaccharide on microcapsule
trapping, colonic nuclearaberrations, andBAP 1,6-diaonetrappingarising from treatment with BaP.a
C57/B6 mice F344 rats
Fat, beefprotein, Total BaP binding Colonic nuclear Total BaPbindin, 1,6-Dione d
and fiber intake by microcapsules aberrations, %C by microcapsules trapped in microcapsules
LF/LB/LNSP 60 3.60 ± 0.25 0.93 ± 0.41 3.9 ± 2.2
HF/LB/LNSP 65 1.30 ± 0.35 ND ND
LF/HB/LNSP 86 2.33 ±0.20 1.04 0.10 13.3 ± 8.8
LF/LB/HNSP 56 1.87 ± 0.31 0.59 ± 0.11 3.6 ± 2.4
LF/HB/HNSP ND ND 0.97 ± 0.02 17.2 + 1.6
Control ND 0.45 ± 0.09e 0.24 0.01f 2.3 ± 1.8f
Abbreviations: BaP, benzo[a]pyrene; H, high; L, low; F, fat; B, beefprotein; NSP, nonstarch polysaccharide; ND, notdetermined.
aRodents treatedperos with['4CJBaP.
bExpressed as pmoles BaP per million microcapsules. C57/B6 mice data frompooled samples (six pergroup).
CColonic nuclear aberration included apoptotic cells and micronuclei.
dExpressed as pmoles BaP 1,6-dione per million microcapsules.
eControl mice consumed LF/LB/LNSP dietbut were not treated with BaP.
fExpressed as pmole BaP 1,6-dione per million microcapsules.
postlabeling, etc., and asecondconsisting ofDNA sequences,
e.g., ras andp53 oncogene sections (8) for which damage is
known to becritical in human GI carcinogenesis.
Both types oftarget would be damaged during the vigorous
acylationreactionsused informingthemicrocapsule membrane.
An approach adopted for the first target type (low molecular
weight) isto insertitintothemicrocapsules aftermembranefor-
mation. Preliminary workwithguanosine-3'-phosphate coupled
by carbodiimide into PEI microcapsules (Ciroussel etal., un-
published data) showed, however, that such target-adducted
microcapsulesyieldedvirtually noN7-methylguanineaftertreat-
ment with ['4CH3d-labeled NMU ormethylmethane sulfonate
(MMS). ItappearedthatthePEImicrocapsulenucleophilicity,
while soeffective intrappingcarcinogenelectrophiles, wastoo
effective inshielding thistarget. Consequently, weloweredthe
residual nucleophilicity ofthemicrocapsule structure(to
- 1%
of PEI structures) by using a poly(vinyl alcohol)-
triethylenetetramine structure and then blocking most of the
amino functions (39).
Abettertargetsubstance(I)hasbeensynthesized(38). While
representing the most reactive DNA site dG deoxyribose is
replacedbyaselectivelycleavablediollinkermoietytoavoidex-
tensive depurination and/or phosphate hydrolysis with conse-
quent loss ofadducted guanine. This has been shown to react
with NMU at a rate and giving 06/N7 product distribution
similar to dG (McGinnis et al., unpublished data). Sodium
periodatecleavageofthetargetlinker, followedbyNaBH4reduc-
tion to give 9-hydroxyethylguanine has been shown and mass
spectrometric assay ofthis cleaved target and several adducts
demonstrated (Farmer etal. unpublisheddata).
Withthecomponentsofthefirsttartsysteminplace, another
task is to incorporate DNA orpolynucleotides into microcap-
sules toprovidethesecondtargettype. Encouragingprogress is
being madeonthistask. Theproblemofintragastrichydrolytic
damage canbeavoidedbyusingenteric-coatedcapsules to con-
tain the microcapsules. Such procedures may provide specific
duodenal release or colonic release (40), and thereby some
discriminationoftheGIsegmentinwhichmicrocapsule trapp-
ing has occured.
Microcapsule Trapping and Dietary
Influenceswithin the Intestinal Milieu
Althoughmany studieshaveexamined substances ofpotential
carcinogenic significance in the GI cavity andthe complex in-
teractionstherein, thereisstilltheproblemthatalteringonecom-
ponent ofdiet or microflora usually has complex and mostly
unknowable consequences to which an observed effect of tu-
morigenesisorfecalexcretion maynotbedirectlyrelated. A se-
condproblemisthatexperimentalworkwithinGImilieuderived
fromcommercial rodentdietsproduces resultstotallyunrelated
tohumanconsumptionandwhichcouldberelatedneithertothe
established dietary etiology ofhuman CR carcinogenesis nor
later to human studies. Hence, diets ofhuman foods were de-
signed to provide all eight permutations (4;Cummings et al.,
submitted)ofindependent, 3-foldalterationsindaily intakesof
thethreeestablishedCRrisk-alteringmacrocomponents, name-
ly, fat (42), beef protein (42), and dietary fiber nonstarch
polysaccharide (NSP; 43).
The set of four low-fat human diets (for which available
calorificintakewasbasedonUKhumanfoodtables) werefound
tobe well accepted and togivethe samebodyweight increases
inF344rats,irrespectiveoffiberorbeefproteinchanges(Cum-
mings etal., submitted). Almostevery biochemical parameter
measured having relevance to carcinogenesis was greatly dif-
ferent from those in a chow control group (5). ['4C]BaP was
givenbygavage, anda setofsystematicalterationsby fiberand
beef protein was found (Table 2) for a) average trapping in
microcapsules (threedosesgivenin48hr), b)thedispositionof
14Cbetweencavity contentsandmicrocapsules, andc) thepat-
tern ofmicrocapsule-trapped metabolites asassayedby HPLC
(4,5). Asecondstudywiththecorrespondinghigh-fatset(Cum-
mings etal., submitted) in F344 rats showed somedifferences
thatmaybeattributable toafat-fiberinteraction. Overall, 3-fold
alterationsofintakewithinthenormalhumanrangecaused2- to
3-foldalterationsinseveralparameterspotentiallyrelatedtothe
effectiveexposurewithintheGItract. Thespecifictrapping on
microcapsulesoftotalBaPmetabolites (nmolepermillion) was
shown to be inversely related to the 3-day fecal weight, w
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FIGURE 1. HPLC-radiochromatograms forthe separation ofbenzo(ajpyrene (BaP) (29.24-30.06 min retention time) and polar metabolites aftermethanol:NH40H
(50:1) extraction from microcapsules following gavage treatmentofF344 ratswith [14C]BaPand PEI microcapsules. Short retention time products (< 5 min)
are (conjugated) BaPtetraols, andthose intime22-27 mins arephenolsanddiones. Microcapsules wererecoveredafterBaP gavage from (a) cecum at4hr; (b)
cecum at 24 hr; and (c) feces at 24 hr.
(R=0.81), as onemightexpectfromdilutionofintestinal contents
(25; Cummings et al., submitted). In turn, w was principally
dominatedby fiber intake(inaccordwith onehypothesis onfiber
action) with w(g) = 0.37 + 0.81 (NSP) + 0.27 (beefprotein).
Thesestudies ofthe rodentintestinal milieuhaveyielded semi-
quantitative effects on microcapsule trapping by altering
epidemiologically establisheddietaryfactorswithinthenormal
human intake range. Theseresults indicatethatsuchdietary fac-
tors mustbecontrolled inseeking sourcesofas-yetunidentified,
endogenous DNA-damaging agents.
Athird study with ['4C]BaP inC57/B6 mice(44) didnotshow
such strikingdifferences inmicrocapsule trapping at24hrafter
gavage, thetimechosen forsacrifice inorderto measurecolonic
nuclear alterations (Table2). These showed largediet-dependent
differences, asdidthepattern ofBaPmetabolites extractedfrom
themicrocapsules (44), butthe small fractionofBaPdose pre-
sentinfeces (24-39%)givesrisetocautionaboutrelativeeffects
ofthefirst-pass BaPmetabolites versusthosetransitinglaterafter
duodenal absorption and enterohepatic circulation and me-
tabolism. Dietary influences onthepharmacodynamics ofBaP
orothercarcinogens haveinfluenced thedietdependence ofboth
theeffectivemucosal exposureandthissnapshotofmicrocapsule
trapping. Furtherwork(Incaurgarat etal., unpublisheddata) was
undertaken to checkthe dependence on time, GI location, and
diet of microcapsule and mucosal DNA adduct formation by
['4C]BaP in F344 rats. As the microcapsules are moved by
peristalsisthroughsuccessiveGIlocations, and appearinfeces,
HPLC assayofextracts frommicrocapsules (Fig. 1)showedthat
BaPproductswithinthemicrocapsules areprogressivelyaltered.
Theproportionofdesorbableproductsdecreasedfrom81 to26%
onpassing fromstomachto feces. Adductformationwithinthe
largebowel wasmeasuredat24hrafter gavageandthemucosal
DNA adductsandthoseformedwithinmicrocapsulesrecovered
from the contents ofthe cavity showed good correlation (r =
0.86, p < 0.005).
Dietdependenceofmicrocapsuletrappingofbothtotal and in-
dividualmetaboliteshasalsobeenshown for[14C]IQgivenper
os (25; Turesky, unpublished data). Thus, for an ingested car-
cinogen, there seems little doubt that carcinogen trapping by
microcapsules is strongly influencedby the closeproximity to
biological eventsanddietary influencesthatdetermineeventual
DNA damage in the CR mucosa.
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Studies in Humans
With total control ofall thedietary consumptions and excre-
tionsofvolunteers residentinaclinical nutritionsuite, ourfirst
objectivehasbeenthestudyofthesystematicalteration inlevels
ofa sequence ofdietary components before proceeding to the
comparison ofhigh versuslow riskpopulations. Thefirststudy
(6) showed lackofill effects frommicrocapsules andextensive
effects as apparently arising from endogenous radical oxidant
precursorsandcross-linkingagents. Oursecondstudyisexamin-
ingtheeffectsoffiberNSPandgrilledbeefonseveralmicrocap-
sulefeaturesdiscussedearlier. Inviewofhighriskforneoplasms
there, we aim also to study the upper GI tract through which
microcapsules move rapidly, and the required technical de-
velopments are being considered. Separation ofeffects from
microcapsules fromexposures intheupperandlowerGItractis
currently beingstudied. Afurtherrequirementformicrocapsule
validation that seems attainable istheuseofethically acceptable
indicatorsofshort-termmucosalchanges. Currentlywecanuse
several microcapsule end points, and we have an exceptional
degree of long-term dietary control, without which human
studies may beuseless. Weshouldbeabletoextrapolateeffects
ofconsumption ofthe samediets between humansand rodents
in which model carcinogens can be used.
Conclusions
For a number ofreasons, biomonitoring the GI tract should
haveimportancefortheetiologyofGIandperhapsothercancers.
Afterovercoming mostofthetechnicalproblemswithmicrocap-
sules, we have shown that microcapsules provide trapping of
covalently bound and/ordesorbable metabolites for all model
carcinogens used. Several different end points were found. In
conjunction withmagnetically maneuvrable substrates thatper-
mit easy recovery, clean-up, and total distinction from any en-
dogenous substrate intheGItract, thesemicrocapsules provide
anumberofadvantages. Manipulationofestablisheddietary risk
factorsproducessubstantialalterationsintrapping, asmightbe
expected fromtheas-yetunprovenassumptionthatcavity levels
ofcarcinogen electrophiles will directly alterGI cancer risk.
This manuscript was presented at the Conference on Biomonitoring and
Susceptibility Markers inHumanCancer: Applications inMolecularEpidem-
iologyandRiskAssessmentthatwasheldinKailua-Kona, Hawaii, 26October-I
November 1991.
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